Your browser doesn't support javascript.
loading
Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study.
Amiaz, Revital; Kent, Ilan; Rubinstein, Katya; Sela, Ben Ami; Javitt, Daniel; Weiser, Mark.
  • Amiaz R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Kent I; Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Rubinstein K; Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Sela BA; Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
  • Javitt D; Nathan Klein Institute, Orangeburg, New York, U.S.A.
  • Weiser M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Isr J Psychiatry Relat Sci ; 52(1): 12-5, 2015.
Article en En | MEDLINE | ID: mdl-25841105
Asunto(s)
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Sarcosina / Esquizofrenia / Antipsicóticos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Search on Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Sarcosina / Esquizofrenia / Antipsicóticos Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article